Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and pharmacodynamic study comparing BIOD-105 and BIOD-107 to Humalog in subjects with Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• BIOD-105
• BIOD-107
• Humalog (insulin lispro)

Snippet

Sponsor: Biodel | Conditions: Diabetes Mellitus Type 1 | Phase 1 | Status: COMPLETED